Johnson & Johnson JNJ
271.22
0.54
0.20%
as of 25 Sep
- Market cap
- $652.8B
- P/E
- 31.4×
Follow JNJ
S&P 500 Member
Dividend Aristocrat
Cash Flow Champion (3y)
Revenue Champion (3y)
Insider Buys (last 12m)
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Johnson & Johnson (JNJ) Operating cash flow
Johnson & Johnson's operating cash flow for fiscal 2025 was $24.5B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $27.6B. Over the past ten years it has ranged from $18.8B (fiscal 2016) to $24.5B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Johnson & Johnson ranks 2nd of 21 Drug Manufacturers General companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $24.5B | 1.09% |
| FY2024 | $24.3B | 6.47% |
| FY2023 | $22.8B | 7.54% |
| FY2022 | $21.2B | (9.47%) |
| FY2021 | $23.4B | (0.54%) |
| FY2020 | $23.5B | 0.51% |
| FY2019 | $23.4B | 5.47% |
| FY2018 | $22.2B | 5.44% |
| FY2017 | $21.1B | 12.20% |
| FY2016 | $18.8B | (4.10%) |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $8.6B | 242.72% |
| Mar 2026 | $2.5B | (65.60%) |
| Dec 2025 | $7.3B | (20.29%) |
| Sep 2025 | $9.2B | 136.44% |
| 42 more quarters | Free account |
Against its own ten years
Low $18.8B
High $24.5B
Ten-year median
$22.8B
Current reading's percentile
100
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| LLY Eli Lilly and Company compare | $28.1B |
| JNJ Johnson & Johnson | $27.6B |
| MRK Merck & Co., Inc. compare | $20.0B |
| ABBV AbbVie Inc. compare | $19.5B |
| NVS Novartis AG compare | $18.4B |
| AZN AstraZeneca PLC compare | $13.7B |
| GILD Gilead Sciences, Inc. compare | $13.6B |
| PFE Pfizer Inc. compare | $13.4B |
| AMGN Amgen Inc. compare | $12.5B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on JNJ
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement